Christopher J. Molloy was officially appointed the chancellor for Rutgers University–New Brunswick in February 2019. He had served as interim chancellor since July 2018. Molloy received his bachelor's degree in pharmacy from Rutgers and his doctoral degree from the joint Rutgers Graduate School of Biomedical Sciences at Robert Wood Johnson Medical School/Graduate School–New Brunswick. He was a post-doctoral fellow at the National Cancer Institute.
Dr. Molloy joined Rutgers University in 2007 as dean of the Ernest Mario School of Pharmacy. In 2011, he was appointed interim provost for biomedical and health sciences and successfully managed the complex integration of Rutgers and most of the former University of Medicine and Dentistry of New Jersey in 2013. Molloy also served as interim chancellor of Rutgers Biomedical and Health Sciences and then senior vice president for the Office of Research and Economic Development until his appointment as interim chancellor.
At Rutgers, he holds a faculty position as Distinguished Professor of Pharmacology and Toxicology and is a member of the Rutgers Cancer Institute of New Jersey, the American Association for Cancer Research, the American Society for Biochemistry and Molecular Biology, and the American Pharmacists Association. He was elected as a Fellow of the American Association for the Advancement of Science in 2016.
Prior to joining Rutgers, Molloy held senior research and management positions at Johnson & Johnson, 3-Dimensional Pharmaceuticals Inc., and Bristol Myers Squibb Pharmaceutical Research Institute. He is also a licensed pharmacist in New Jersey.